title: Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability: radionuclide comparison before and after revascularization.
abstract: BACKGROUND
  Nitroglycerin (NTG) is known to increase the blood supply to the myocardium, and would thus increase the delivery of a perfusional tracer such as sestamibi (MIBI) to the tissue. The latter, in turn, would take up and concentrate the tracer to a greater extent than in basal conditions only if energy-dependent mechanisms were still available-that is, only if the cells were still viable.
  
  
  METHODS
  We evaluated the changes that intravenous administration of NTG induced on the uptake of MIBI by akinetic myocardial areas, using tomographic perfusional imaging in 23 patients with previously ascertained anterior myocardial infarction who were undergoing myocardial revascularization procedures. Changes in uptake were compared with echocardiographic and perfusional changes occurring after operation.
  
  
  RESULTS
  The improvement of MIBI uptake after NTG correctly identified 12 of the 16 patients (75%) showing postoperative wall motion improvement; they comprised 12 of the 14 (86%) patients with NTG-induced increase in MIBI uptake who showed improved wall motion after operation. A close correlation (r = 0.88, P < 0.001) was found between the increase in myocardial MIBI uptake induced by NTG infusion and that induced by revascularization. The presence of collaterals to the akinetic area was associated with a significantly (P < 0.01) greater increase in MIBI uptake both during NTG infusion and after operation.
  
  
  CONCLUSIONS
  The results of this study suggest that MIBI perfusional myocardial scintigraphy during infusion of NTG is capable of detecting viable but chronically hypoperfused myocardium, predicting postoperative wall motion and perfusional improvement, and reflecting the postoperative pattern of perfusion. The best results were achieved in patients with evidence of collateral circulation supplying the infarcted area.
authors.affiliation: Institute of Cardiac Surgery, University La Sapienza, Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Greco
authors.forename: G
authors.initials: G
authors.lastname: Tanzilli
authors.forename: M
authors.initials: M
authors.lastname: Ciavolella
authors.forename: R
authors.initials: R
authors.lastname: Sinatra
authors.forename: M
authors.initials: M
authors.lastname: Banci
authors.forename: O
authors.initials: O
authors.lastname: Schillaci
authors.forename: F
authors.initials: F
authors.lastname: Macrina
authors.forename: F
authors.initials: F
authors.lastname: Scopinaro
authors.forename: B
authors.initials: B
authors.lastname: Marino
authors.forename: P P
authors.initials: PP
authors.lastname: Campa
mesh_terms: D006328:Cardiac Catheterization; D002470:Cell Survival; D003097:Collateral Circulation; D017023:Coronary Angiography; D004452:Echocardiography; D006321:Heart / Q000000981:diagnostic imaging* / Q000187:drug effects*; D006801:Humans; D009200:Myocardial Contraction; D009204:Myocardial Revascularization; D009206:Myocardium / Q000378:metabolism*; D005996:Nitroglycerin; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D019275:Radiopharmaceuticals; D014665:Vasodilator Agents; D017256:Technetium Tc 99m Sestamibi; D005996:Nitroglycerin